Title : Ipragliflozin Add-on Therapy to a GLP-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes (AGATE): A 52-Week Open-Label Study.

Pub. Date : 2018 Aug

PMID : 29926400






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Ipragliflozin Add-on Therapy to a GLP-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes (AGATE): A 52-Week Open-Label Study. ipragliflozin glucagon like peptide 1 receptor Homo sapiens
2 The results from this study suggest that ipragliflozin can be recommended as a well-tolerated and effective add-on therapy to a GLP-1 receptor agonist for the treatment of T2DM. ipragliflozin glucagon like peptide 1 receptor Homo sapiens